Concepts and Core Principles of Fragment-Based Drug Design

被引:139
|
作者
Kirsch, Philine [1 ,2 ]
Hartman, Alwin M. [1 ,3 ]
Hirsch, Anna K. H. [1 ,3 ]
Empting, Martin [1 ,2 ]
机构
[1] Helmholtz Ctr Infect Res HZI, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Drug Design & Optimizat DDOP, Campus E8-1, D-66123 Saarbrucken, Germany
[2] Saarland Univ, Dept Pharm, Campus E8-1, D-66123 Saarbrucken, Germany
[3] Univ Groningen, Stratingh Inst Chem, Nijenborgh 7, NL-9747 AG Groningen, Netherlands
来源
MOLECULES | 2019年 / 24卷 / 23期
关键词
fragment-based drug design; biophysical screening; rule-of-three; ligand efficiency; fragment optimization; DIFFERENTIAL SCANNING FLUOROMETRY; DYNAMIC COMBINATORIAL CHEMISTRY; SURFACE-PLASMON RESONANCE; THERMAL SHIFT ASSAYS; MICROSCALE THERMOPHORESIS; HIGH-THROUGHPUT; PSEUDOMONAS-AERUGINOSA; LIGAND INTERACTIONS; HIT IDENTIFICATION; CHEMICAL SPACE;
D O I
10.3390/molecules24234309
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this review, a general introduction to fragment-based drug design and the underlying concepts is given. General considerations and methodologies ranging from library selection/construction over biophysical screening and evaluation methods to in-depth hit qualification and subsequent optimization strategies are discussed. These principles can be generally applied to most classes of drug targets. The examples given for fragment growing, merging, and linking strategies at the end of the review are set in the fields of enzyme-inhibitor design and macromolecule-macromolecule interaction inhibition. Building upon the foundation of fragment-based drug discovery (FBDD) and its methodologies, we also highlight a few new trends in FBDD.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] In silico fragment-based drug design
    Konteatis, Zenon D.
    EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (11) : 1047 - 1065
  • [2] Fragment-based QSAR: perspectives in drug design
    Salum, Livia B.
    Andricopulo, Adriano D.
    MOLECULAR DIVERSITY, 2009, 13 (03) : 277 - 285
  • [3] In Silico Approaches for Fragment-based Drug Design
    Takahashi, Osamu
    Masuda, Yoshiaki
    Muroya, Ayumu
    Furuya, Toshio
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (03): : 349 - 354
  • [4] The ways and means of fragment-based drug design
    Doak, Bradley C.
    Norton, Raymond S.
    Scanlon, Martin J.
    PHARMACOLOGY & THERAPEUTICS, 2016, 167 : 28 - 37
  • [5] Applications of ?linkers? in fragment-based drug design
    Wu, Xin
    Zhang, Yuan
    Liu, Songbin
    Liu, Chang
    Tang, Guotao
    Cao, Xuan
    Lei, Xiaoyong
    Peng, Junmei
    BIOORGANIC CHEMISTRY, 2022, 127
  • [6] Comptational methods in fragment-based drug design
    Williams, Chris
    Leonard, Joseph M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [7] Puzzling through fragment-based drug design
    Hajduk, Philip J.
    NATURE CHEMICAL BIOLOGY, 2006, 2 (12) : 658 - 659
  • [8] Fragment-based QSAR: perspectives in drug design
    Lívia B. Salum
    Adriano D. Andricopulo
    Molecular Diversity, 2009, 13 : 277 - 285
  • [9] Fragment-based QSAR strategies in drug design
    Salum, Livia B.
    Andricopulo, Adriano D.
    EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (05) : 405 - 412
  • [10] Puzzling through fragment-based drug design
    Philip J Hajduk
    Nature Chemical Biology, 2006, 2 : 658 - 659